Relationship between high-density lipoprotein cholesterol levels and endothelial function in women: a cross-sectional study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
07 07 2020
Historique:
entrez: 10 7 2020
pubmed: 10 7 2020
medline: 15 5 2021
Statut: epublish

Résumé

The purpose of this study was to evaluate the relationship between high-density lipoprotein cholesterol (HDL-C) levels and endothelial function in women. Cross-sectional study. 22 university hospitals and affiliated clinics in Japan. 1719 Japanese women aged 17-90 years who were not receiving lipid-lowering therapy. We evaluated flow-mediated vasodilation (FMD) and serum levels of HDL-C. All participants were divided into four groups by HDL-C level: low HDL-C (<40 mg/dL), moderate HDL-C (40-59 mg/dL), high HDL-C (60-79 md/dL) and extremely high HDL-C (≥80 mg/dL). Univariate regression analysis revealed a significant relationship between FMD and HDL-C (r=0.12, p<0.001). FMD values were significantly smaller in the low HDL-C group (5.2%±3.8%) and moderate HDL-C group (5.2%±3.8%) than in the extremely high HDL-C group (6.7%±3.4%) (p=0.024 and p=0.003, respectively), while there was no significant difference in FMD between the high HDL-C group and the extremely high HDL-C group. Multiple logistic regression analysis did not show a significant association between HDL-C levels and FMD. Endothelial function increased in relation to HDL-C levels. However, there was no association of HDL-C levels with endothelial function after adjustment of traditional cardiovascular risk factors in women. UMIN000012950; Results.

Identifiants

pubmed: 32641366
pii: bmjopen-2020-038121
doi: 10.1136/bmjopen-2020-038121
pmc: PMC7342861
doi:

Substances chimiques

Cholesterol, HDL 0
Triglycerides 0

Banques de données

UMIN-CTR
['UMIN000012950']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e038121

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Circulation. 1989 Jan;79(1):8-15
pubmed: 2642759
Circulation. 2009 Mar 3;119(8):1135-45
pubmed: 19221221
Atherosclerosis. 2016 Oct;253:75-80
pubmed: 27591364
Cardiovasc Res. 2014 Aug 1;103(3):350-61
pubmed: 24935432
N Engl J Med. 1999 Jan 14;340(2):115-26
pubmed: 9887164
Nat Rev Cardiol. 2016 Jan;13(1):48-60
pubmed: 26323267
PLoS One. 2012;7(3):e31930
pubmed: 22403620
Prev Med. 1998 Sep-Oct;27(5 Pt 1):659-67
pubmed: 9808796
JAMA. 1986 Nov 28;256(20):2835-8
pubmed: 3773200
Stroke. 2012 Jul;43(7):1768-74
pubmed: 22496337
Atherosclerosis. 2003 Jan;166(1):177-85
pubmed: 12482565
Circulation. 2017 Jun 20;135(25):2494-2504
pubmed: 28450350
Circulation. 2001 Jan 2;103(1):108-12
pubmed: 11136694
Circ J. 2009 Mar;73(3):411-8
pubmed: 19194043
Circulation. 1998 May 12;97(18):1837-47
pubmed: 9603539
J Clin Lipidol. 2016 Jul-Aug;10(4):962-969
pubmed: 27578129
J Lipid Res. 2013 Dec;54(12):3227-43
pubmed: 23873269
Nihon Naika Gakkai Zasshi. 2005 Apr 10;94(4):794-809
pubmed: 15865013
J Clin Lipidol. 2009 Oct;3(5):345-50
pubmed: 21291833
PLoS One. 2018 Mar 15;13(3):e0192616
pubmed: 29543843
Int J Cardiol. 2000 May 31;73(3):231-6
pubmed: 10841964
N Engl J Med. 2012 Nov 29;367(22):2089-99
pubmed: 23126252
Am J Med. 1977 May;62(5):707-14
pubmed: 193398
N Engl J Med. 2017 May 18;376(20):1933-1942
pubmed: 28514624
N Engl J Med. 2007 Nov 22;357(21):2109-22
pubmed: 17984165
Diabetes Care. 1999 Jan;22 Suppl 1:S1-114
pubmed: 10333970
Circulation. 2002 Mar 26;105(12):1399-402
pubmed: 11914243
J Am Coll Cardiol. 2009 Oct 20;54(17):1561-75
pubmed: 19833255
Mol Cell Biochem. 2018 Mar;440(1-2):167-187
pubmed: 28828539
Int Heart J. 2012;53(3):170-5
pubmed: 22790685
J Clin Invest. 2003 May;111(10):1579-87
pubmed: 12750408
N Engl J Med. 2014 Dec 18;371(25):2383-93
pubmed: 25404125
J Clin Invest. 2004 Feb;113(4):569-81
pubmed: 14966566
Biochem Biophys Res Commun. 2003 Oct 10;310(1):98-103
pubmed: 14511654
J Clin Lipidol. 2019 Jul - Aug;13(4):664-672.e1
pubmed: 31311726
N Engl J Med. 1990 Nov 1;323(18):1234-8
pubmed: 2215607
J Clin Lipidol. 2018 May - Jun;12(3):674-684.e5
pubmed: 29506864
Atherosclerosis. 2012 Jun;222(2):390-4
pubmed: 22456230
J Am Heart Assoc. 2015 Nov 13;4(11):
pubmed: 26567372
Nat Med. 2001 Jul;7(7):853-7
pubmed: 11433352
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2236-2244
pubmed: 30026268
Circ Res. 2008 Feb 29;102(4):480-7
pubmed: 18174467
Circulation. 1980 Nov;62(4 Pt 2):IV41-52
pubmed: 7418143
Diabet Med. 1998 Jul;15(7):539-53
pubmed: 9686693
Metabolism. 2003 Dec;52(12):1564-70
pubmed: 14669156
J Atheroscler Thromb. 2016 Jul 1;23(7):800-9
pubmed: 26923252
Atherosclerosis. 2017 Oct;265:147-154
pubmed: 28888808
Circulation. 1994 Jun;89(6):2533-9
pubmed: 8205661
Int J Cardiovasc Imaging. 2010 Aug;26(6):631-40
pubmed: 20339920

Auteurs

Yuji Takaeko (Y)

Department of Cardiovascular Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Shogo Matsui (S)

Department of Cardiovascular Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Masato Kajikawa (M)

Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan.

Tatsuya Maruhashi (T)

Department of Cardiovascular Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Takayuki Yamaji (T)

Department of Cardiovascular Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Takahiro Harada (T)

Department of Cardiovascular Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Yiming Han (Y)

Department of Cardiovascular Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Haruki Hashimoto (H)

Department of Cardiovascular Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Yasuki Kihara (Y)

Department of Cardiovascular Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Eisuke Hida (E)

Department of Biostatistics and Data Science, Osaka University Graduate School of Medicine, Osaka, Japan.

Kazuaki Chayama (K)

Department of Gastroenterology and Metabolism, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Chikara Goto (C)

Department of Physical Therapy, Hiroshima International University, HigashiHiroshima, Hiroshima, Japan.

Yoshiki Aibara (Y)

Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima, Japan.

Farina Mohamad Yusoff (FM)

Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima, Japan.

Shinji Kishimoto (S)

Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima, Japan.

Ayumu Nakashima (A)

Department of Stem Cell Biology and Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Yukihito Higashi (Y)

Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan yhigashi@hiroshima-u.ac.jp.
Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH